SIMULATIONS PLUS INC (SLP) Stock Fundamental Analysis

NASDAQ:SLP • US8292141053

12.23 USD
+0.14 (+1.16%)
At close: Feb 27, 2026
12.19 USD
-0.04 (-0.33%)
After Hours: 2/27/2026, 8:00:02 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

6

We assign a fundamental rating of 6 out of 10 to SLP. SLP was compared to 35 industry peers in the Health Care Technology industry. While SLP has a great health rating, its profitability is only average at the moment. SLP is not overvalued while it is showing excellent growth. This is an interesting combination.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

  • SLP had positive earnings in the past year.
  • In the past year SLP had a positive cash flow from operations.
  • Of the past 5 years SLP 4 years were profitable.
  • SLP had a positive operating cash flow in each of the past 5 years.
SLP Yearly Net Income VS EBIT VS OCF VS FCFSLP Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20M -20M -40M -60M

1.2 Ratios

  • SLP has a Return On Assets of -46.61%. This is in the lower half of the industry: SLP underperforms 68.57% of its industry peers.
  • The Return On Equity of SLP (-50.54%) is comparable to the rest of the industry.
  • SLP has a better Return On Invested Capital (4.45%) than 74.29% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for SLP is below the industry average of 7.08%.
  • The 3 year average ROIC (3.61%) for SLP is below the current ROIC(4.45%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA -46.61%
ROE -50.54%
ROIC 4.45%
ROA(3y)-12.88%
ROA(5y)-5.32%
ROE(3y)-13.51%
ROE(5y)-5.53%
ROIC(3y)3.61%
ROIC(5y)4.56%
SLP Yearly ROA, ROE, ROICSLP Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 -40

1.3 Margins

  • Looking at the Operating Margin, with a value of 9.00%, SLP belongs to the top of the industry, outperforming 82.86% of the companies in the same industry.
  • SLP's Operating Margin has declined in the last couple of years.
  • SLP has a Gross Margin (59.60%) which is in line with its industry peers.
  • SLP's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 9%
PM (TTM) N/A
GM 59.6%
OM growth 3Y-33.32%
OM growth 5Y-21.72%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-9.94%
GM growth 5Y-4.73%
SLP Yearly Profit, Operating, Gross MarginsSLP Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50 -50

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

8

2. Health

2.1 Basic Checks

  • SLP has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • The number of shares outstanding for SLP has been increased compared to 1 year ago.
  • The number of shares outstanding for SLP has been increased compared to 5 years ago.
  • There is no outstanding debt for SLP. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
SLP Yearly Shares OutstandingSLP Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M 20M
SLP Yearly Total Debt VS Total AssetsSLP Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M

2.2 Solvency

  • SLP has an Altman-Z score of 14.61. This indicates that SLP is financially healthy and has little risk of bankruptcy at the moment.
  • SLP has a Altman-Z score of 14.61. This is amongst the best in the industry. SLP outperforms 91.43% of its industry peers.
  • SLP has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 14.61
ROIC/WACC0.48
WACC9.22%
SLP Yearly LT Debt VS Equity VS FCFSLP Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M

2.3 Liquidity

  • SLP has a Current Ratio of 5.62. This indicates that SLP is financially healthy and has no problem in meeting its short term obligations.
  • SLP's Current ratio of 5.62 is amongst the best of the industry. SLP outperforms 85.71% of its industry peers.
  • A Quick Ratio of 5.62 indicates that SLP has no problem at all paying its short term obligations.
  • Looking at the Quick ratio, with a value of 5.62, SLP belongs to the top of the industry, outperforming 85.71% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 5.62
Quick Ratio 5.62
SLP Yearly Current Assets VS Current LiabilitesSLP Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

7

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an impressive 50.00% over the past year.
  • SLP shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 1.07% yearly.
  • The Revenue has been growing slightly by 5.69% in the past year.
  • SLP shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 13.74% yearly.
EPS 1Y (TTM)50%
EPS 3Y-1.12%
EPS 5Y1.07%
EPS Q2Q%200%
Revenue 1Y (TTM)5.69%
Revenue growth 3Y13.67%
Revenue growth 5Y13.74%
Sales Q2Q%-2.66%

3.2 Future

  • Based on estimates for the next years, SLP will show a very strong growth in Earnings Per Share. The EPS will grow by 22.12% on average per year.
  • SLP is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 10.38% yearly.
EPS Next Y-5.97%
EPS Next 2Y-1.9%
EPS Next 3Y3.05%
EPS Next 5Y22.12%
Revenue Next Year2.12%
Revenue Next 2Y4.05%
Revenue Next 3Y5.79%
Revenue Next 5Y10.38%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
SLP Yearly Revenue VS EstimatesSLP Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 50M 100M 150M
SLP Yearly EPS VS EstimatesSLP Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 1 -1 -2 -3

More info and screens

Find the best growth stocksShow best growing peers

4

4. Valuation

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 20.38 indicates a rather expensive valuation of SLP.
  • Based on the Price/Earnings ratio, SLP is valued a bit cheaper than 77.14% of the companies in the same industry.
  • SLP's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 27.07.
  • The Price/Forward Earnings ratio is 21.91, which indicates a rather expensive current valuation of SLP.
  • SLP's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. SLP is cheaper than 65.71% of the companies in the same industry.
  • The average S&P500 Price/Forward Earnings ratio is at 28.05. SLP is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 20.38
Fwd PE 21.91
SLP Price Earnings VS Forward Price EarningsSLP Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

  • 65.71% of the companies in the same industry are more expensive than SLP, based on the Enterprise Value to EBITDA ratio.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of SLP indicates a rather cheap valuation: SLP is cheaper than 82.86% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 12.37
EV/EBITDA 14.28
SLP Per share dataSLP EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)19.09
EPS Next 2Y-1.9%
EPS Next 3Y3.05%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

3

5. Dividend

5.1 Amount

  • With a yearly dividend of 0.61%, SLP is not a good candidate for dividend investing.
  • In the last 3 months the price of SLP has falen by -28.06%. A price decline artificially increases the dividend yield. It may be a sign investors do not expect the dividend to last.
  • SLP's Dividend Yield is rather good when compared to the industry average which is at 0.60. SLP pays more dividend than 94.29% of the companies in the same industry.
  • With a Dividend Yield of 0.61, SLP pays less dividend than the S&P500 average, which is at 1.82.
Industry RankSector Rank
Dividend Yield 0.61%

5.2 History

  • SLP has been paying a dividend for at least 10 years, so it has a reliable track record.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
SLP Yearly Dividends per shareSLP Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 0.05 0.1 0.15 0.2

5.3 Sustainability

DP0%
EPS Next 2Y-1.9%
EPS Next 3Y3.05%
SLP Yearly Income VS Free CF VS DividendSLP Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -20M -40M -60M

More info and screens

Find the best dividend stocksShow peers with best dividend

SIMULATIONS PLUS INC

NASDAQ:SLP (2/27/2026, 8:00:02 PM)

After market: 12.19 -0.04 (-0.33%)

12.23

+0.14 (+1.16%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)01-08
Earnings (Next)04-01
Inst Owners79.38%
Inst Owner Change-1.33%
Ins Owners17.2%
Ins Owner Change0.12%
Market Cap246.43M
Revenue(TTM)78.68M
Net Income(TTM)-64.25M
Analysts76.36
Price Target25.25 (106.46%)
Short Float %7.21%
Short Ratio3.35
Dividend
Industry RankSector Rank
Dividend Yield 0.61%
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-18.28%
Min EPS beat(2)-77.15%
Max EPS beat(2)40.59%
EPS beat(4)3
Avg EPS beat(4)71.31%
Min EPS beat(4)-77.15%
Max EPS beat(4)321.12%
EPS beat(8)4
Avg EPS beat(8)23.48%
EPS beat(12)5
Avg EPS beat(12)8.75%
EPS beat(16)7
Avg EPS beat(16)5.82%
Revenue beat(2)2
Avg Revenue beat(2)1.06%
Min Revenue beat(2)0.77%
Max Revenue beat(2)1.36%
Revenue beat(4)4
Avg Revenue beat(4)1.01%
Min Revenue beat(4)0.63%
Max Revenue beat(4)1.36%
Revenue beat(8)6
Avg Revenue beat(8)0.57%
Revenue beat(12)7
Avg Revenue beat(12)-0.44%
Revenue beat(16)10
Avg Revenue beat(16)0.08%
PT rev (1m)4.21%
PT rev (3m)7.61%
EPS NQ rev (1m)0%
EPS NQ rev (3m)43.64%
EPS NY rev (1m)-1.37%
EPS NY rev (3m)34.16%
Revenue NQ rev (1m)-0.36%
Revenue NQ rev (3m)-0.38%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.6%
Valuation
Industry RankSector Rank
PE 20.38
Fwd PE 21.91
P/S 3.13
P/FCF 12.37
P/OCF 10.43
P/B 1.94
P/tB 4.51
EV/EBITDA 14.28
EPS(TTM)0.6
EY4.91%
EPS(NY)0.56
Fwd EY4.56%
FCF(TTM)0.99
FCFY8.08%
OCF(TTM)1.17
OCFY9.59%
SpS3.9
BVpS6.31
TBVpS2.71
PEG (NY)N/A
PEG (5Y)19.09
Graham Number9.23
Profitability
Industry RankSector Rank
ROA -46.61%
ROE -50.54%
ROCE 5.55%
ROIC 4.45%
ROICexc 6.18%
ROICexgc 29.44%
OM 9%
PM (TTM) N/A
GM 59.6%
FCFM 25.32%
ROA(3y)-12.88%
ROA(5y)-5.32%
ROE(3y)-13.51%
ROE(5y)-5.53%
ROIC(3y)3.61%
ROIC(5y)4.56%
ROICexc(3y)6.84%
ROICexc(5y)12.7%
ROICexgc(3y)60.47%
ROICexgc(5y)79.01%
ROCE(3y)4.51%
ROCE(5y)5.69%
ROICexgc growth 3Y-33.77%
ROICexgc growth 5Y-24.05%
ROICexc growth 3Y-37.37%
ROICexc growth 5Y-22.33%
OM growth 3Y-33.32%
OM growth 5Y-21.72%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-9.94%
GM growth 5Y-4.73%
F-Score6
Asset Turnover0.57
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 50.91%
Cap/Sales 4.72%
Interest Coverage 250
Cash Conversion 164.46%
Profit Quality N/A
Current Ratio 5.62
Quick Ratio 5.62
Altman-Z 14.61
F-Score6
WACC9.22%
ROIC/WACC0.48
Cap/Depr(3y)77.49%
Cap/Depr(5y)94.25%
Cap/Sales(3y)6%
Cap/Sales(5y)7.05%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)50%
EPS 3Y-1.12%
EPS 5Y1.07%
EPS Q2Q%200%
EPS Next Y-5.97%
EPS Next 2Y-1.9%
EPS Next 3Y3.05%
EPS Next 5Y22.12%
Revenue 1Y (TTM)5.69%
Revenue growth 3Y13.67%
Revenue growth 5Y13.74%
Sales Q2Q%-2.66%
Revenue Next Year2.12%
Revenue Next 2Y4.05%
Revenue Next 3Y5.79%
Revenue Next 5Y10.38%
EBIT growth 1Y33.64%
EBIT growth 3Y-24.21%
EBIT growth 5Y-10.96%
EBIT Next Year143.82%
EBIT Next 3Y43.31%
EBIT Next 5Y28.01%
FCF growth 1Y53.44%
FCF growth 3Y1.12%
FCF growth 5Y11.57%
OCF growth 1Y36.52%
OCF growth 3Y0.42%
OCF growth 5Y10.69%

SIMULATIONS PLUS INC / SLP FAQ

What is the ChartMill fundamental rating of SIMULATIONS PLUS INC (SLP) stock?

ChartMill assigns a fundamental rating of 6 / 10 to SLP.


Can you provide the valuation status for SIMULATIONS PLUS INC?

ChartMill assigns a valuation rating of 4 / 10 to SIMULATIONS PLUS INC (SLP). This can be considered as Fairly Valued.


How profitable is SIMULATIONS PLUS INC (SLP) stock?

SIMULATIONS PLUS INC (SLP) has a profitability rating of 4 / 10.


What is the financial health of SIMULATIONS PLUS INC (SLP) stock?

The financial health rating of SIMULATIONS PLUS INC (SLP) is 8 / 10.


Can you provide the expected EPS growth for SLP stock?

The Earnings per Share (EPS) of SIMULATIONS PLUS INC (SLP) is expected to decline by -5.97% in the next year.